Skip to main content

Day: September 8, 2021

CPS Technologies Corp. Announces New Hermetic Packaging Business from Key Customers

NORTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — CPS Technologies Corp. (Nasdaq:CPSH), announced today that several recent contract awards have resulted in over $11 million in orders this year for a variety of Hermetic Packages offered by CPS. Michael McCormack, President and Chief Executive Officer of CPS, said, “All three of our product lines continue to perform well. In particular, the performance of the Hermetic Package product line continues to achieve record results in terms of revenue, and bookings adding significantly to CPS’s bottom line. We have several large customers that have selected CPS solutions to meet their rigorous requirements. We are pleased to be selected as their partner of choice in these critical applications.” “The continued growth of Hermetic Packages for use in Aerospace, Defense and Power Electronics,...

Continue reading

Rhythm Pharmaceuticals Announces Expanded Access Program for Setmelanotide for Patients with Bardet-Biedl Syndrome

Expanded access program may allow access for eligible patients in the United States who have no authorized treatment options BOSTON, Sept. 08, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced an Expanded Access Program (EAP) for setmelanotide for the treatment of eligible patients in the United States with severe obesity and hyperphagia due to Bardet-Biedl Syndrome (BBS). Rhythm expects to submit to the U.S. Food and Drug Administration (FDA) a supplemental new drug application (sNDA) for setmelanotide for the treatment of adult and pediatric patients 6 years of age and older with hunger and obesity due to BBS by the end of September. “BBS is a serious disease...

Continue reading

Capital Southwest Supports Eden Capital’s Acquisition of Wall Street Prep Inc.

DALLAS, Sept. 08, 2021 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it recently supported Eden Capital′s (“Eden”) acquisition of Wall Street Prep, Inc. (“WSP”) with a revolving credit facility, first lien term loan, and a minority equity co-investment. Capital Southwest led the financing and will act as the sole administrative agent. Main Street Capital Corporation also participated in the investment. “We are excited to partner with Eden Capital on this transaction as they continue to pursue investments in the education and corporate training sector,” said Ryan Kelly, Managing Director of Capital...

Continue reading

Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.

DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that its shareholders have voted to approve the previously announced proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) (“Xeris”). As described below, at least 99 percent of the votes cast at both a special court-ordered meeting of shareholders (the “Court Meeting”) and at an extraordinary general meeting of shareholders (the “EGM”) were in favor of the transaction, representing (in each case) approximately 67 percent of the shares outstanding and eligible to be voted at each of the Strongbridge shareholder meetings held on September 8, 2021 in Pennsylvania, United States of America. Upon close of the transaction, the business of Xeris and...

Continue reading

Descartes Announces Fiscal 2022 Second Quarter Financial Results

Record Revenues and Income from Operations WATERLOO, Ontario, Sept. 08, 2021 (GLOBE NEWSWIRE) — The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2022 second quarter (Q2FY22). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “We continue to focus on helping our customers thrive in the face of an increasingly dynamic, complex global trade landscape, and in turn our customers continue to trust us with more of their business” said Edward J. Ryan, Descartes’ CEO. “The challenges and opportunities faced by our customers can vary for shippers, carriers, logistics service providers and customs authorities, but all parties need to connect and collaborate...

Continue reading

ProQR Announces Axiomer® RNA Editing Licensing and Research Collaboration with Lilly

Companies will collaborate to develop editing oligonucleotides directed to up to five targets using ProQR’s proprietary Axiomer® RNA editing platform ProQR to receive $50 million consisting of upfront payment and equity investment ProQR is eligible to additionally receive up to approximately $1.25 billion in research, development, and commercialization milestones, plus royaltiesLEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) —  ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), today announced a global licensing and research collaboration with Eli Lilly and Company (Lilly) focused on the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The companies will use ProQR’s proprietary Axiomer® RNA editing platform to progress new...

Continue reading

Freddie Mac Prices $745 Million Multifamily K-Deal, K-F120

MCLEAN, Va., Sept. 08, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) has priced a new offering of Structured Pass-Through Certificates (K Certificates), which includes a class of floating rate bonds indexed to the Secured Overnight Financing Rate (SOFR). The approximately $745 million in K Certificates (K-F120 Certificates) are expected to settle on or about September 16, 2021. The K-F120 Certificates are backed by floating-rate multifamily mortgages with 10-year terms, which are SOFR-based. K-F120 PricingClass Principal/Notional Amount (mm) Weighted Average Life (Years) Discount Margin Coupon Dollar PriceAS $745.333 9.58 20 30-day SOFR avg + 20 100.000XS Non-OfferedDetailsCo-Lead Managers and Joint Bookrunners: J.P. Morgan Securities LLC and BMO Capital Markets Corp. Co-Managers: Citigroup Global Markets Inc.,...

Continue reading

INDUS to Participate in the BMO Capital Markets 2021 Real Estate Conference

NEW YORK, Sept. 08, 2021 (GLOBE NEWSWIRE) — INDUS Realty Trust, Inc. (Nasdaq: INDT) (“INDUS”), a U.S. based industrial/logistics REIT, announced today that it will participate in the BMO Capital Markets 2021 Real Estate Conference to be held virtually on September 14, 2021. In connection with the conference, INDUS will be sharing an updated investor presentation which will be made available on the Investors section of its website at www.indusrt.com on Monday evening, September 13, 2021. About INDUS INDUS is a real estate business principally engaged in developing, acquiring, managing and leasing industrial/logistics properties. INDUS owns 43 buildings totaling approximately 5.3 million square feet (including 33 industrial/logistics buildings aggregating approximately 4.9 million square feet) in Connecticut, Pennsylvania, North...

Continue reading

PyroGenesis Confirms Securing Additional Government Funding of $630,000 to Develop Novel Production Process to Transform Quartz into Fumed Silica

Total Funding of $5.3MM MONTREAL, Sept. 08, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions to reduce greenhouse gases, today is pleased to confirm that, further to its press releases dated May 27th and July 6th, 2021, it has now received $630,000 in additional funding from a second government agency, for a total project value of approximately $5.3MM (including sale of IP of $3.3MM), all to be received by the Company. As previously disclosed, PyroGenesis, in partnership with HPQ Silica Polvere Inc. (“HPQ Polvere”) a wholly owned subsidiary of HPQ Silicon Resources Inc. (“HPQ”), has...

Continue reading

Magnite to Webcast Investor Day September 15, 2021

LOS ANGELES, Sept. 08, 2021 (GLOBE NEWSWIRE) — Magnite (Nasdaq: MGNI), the largest independent sell-side advertising platform and CTV leader, will webcast its Investor Day on Wednesday, September 15, 2021 from 11 am to 2 pm eastern time. Speakers to include:Michael Barrett, President & CEO Adam Soroca, Chief Product Officer J. Allen Dove, Chief Technology Officer Katie Evans, Chief Operating Officer Sean Buckley, Chief Revenue Officer – CTV Joe Prusz, Chief Revenue Officer – DV+ David Day, CFO Nick Kormeluk, SVP IR & Real EstateWebcast Details   http://investor.magnite.com, under “Events and Presentations”About Magnite We’re Magnite (NASDAQ: MGNI), the world’s largest independent sell-side advertising platform. Publishers use our technology to monetize their content across all screens and formats including...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.